Interpace Biosciences
IDXG
#11365
Rank
N/A
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Interpace Biosciences (IDXG)

Earnings in 2026 (TTM): S$5.19 Million

According to Interpace Biosciences's latest financial reports the company's current earnings are S$36.14 Million. In 2025 the company made an earning of S$5.03 Million a decrease over its 2024 earnings that were of S$11.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Interpace Biosciences from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$5.19 M3.15%
2025 S$5.03 M-54.26%
2024 S$11.01 M303.23%
2023 S$2.73 M-144.63%
2022 -S$6.13 Million-60.98%
2021 -S$15.7 Million-52.04%
2020 -S$32.72 Million-2.68%
2019 -S$33.62 Million121.84%
2018 -S$15.16 Million-6.07%
2017 -S$16.14 Million96.31%
2016 -S$8.22 Million-86.7%
2015 -S$61.8 Million382.48%
2014 -S$12.81 Million134.35%
2013 -S$5.47 Million323.89%
2012 -S$1.29 Million-79.01%
2011 -S$6.15 Million29.08%
2010 -S$4.76 Million-82.57%
2009 -S$27.31 Million-39.28%
2008 -S$44.97 Million146.45%
2007 -S$18.25 Million-269.18%
2006 S$10.78 M-131.08%
2005 -S$34.7 Million-177.16%
2004 S$44.96 M78.33%
2003 S$25.21 M-142.02%
2002 -S$60.02 Million-469.63%
2001 S$16.23 M-68.92%
2000 S$52.23 M140.45%
1999 S$21.72 M
1997 S$3.06 M